NASDAQHealth CareMedical Care FacilitiesSnapshot 2026-07-23
Reading PNTG? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a stable growth opportunity with a medium confidence level. The current thesis state is intact, supported by strong recent financial results and a positive sector environment.
The valuation is considered expensive compared to peers, with a slight expectations gap indicating that the market has priced in a lot of positive sentiment. The company is trading at a premium of 1.6 times its peers, suggesting high expectations for future performance.
Management is on track to meet its revenue growth targets, although earnings per share (EPS) and EBITDA goals show mixed progress. The near-term risk of missing estimates is low, but the company operates in a smaller-cap space where misses can happen.
The long-term thesis hinges on the performance of sector bellwethers like HCA, THC, and DVA. If these companies continue to exceed earnings expectations, PNTG could benefit from the sector momentum. Conversely, any negative guidance from these peers could impact PNTG's outlook.
Overall, PNTG is positioned well within a supportive sector, but its future performance will depend on broader industry trends and management execution. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: Earnings results will show if revenue and EPS targets are on track. This is key for investor confidence.
Confirms one read:Q2 earnings report shows revenue growth of at least 25% year over year.
Confirms the other:Q2 earnings report shows revenue growth below 20% year over year.
Why it matters: Earnings results can provide insights into company performance and future outlook. This is crucial for investors.
Confirms one read:Earnings report shows revenue growth and positive guidance.
Confirms the other:The earnings report shows falling revenue and bad guidance.
Why it matters: Revenue growth is key to reaching the annual target of $1.133B-$1.172B. A drop could signal trouble.
Confirms:Q2 revenue growth is reported below 36% year over year.
Disproves:Q2 revenue growth meets or exceeds 36% year over year.
Why it matters: Hitting this EPS number shows progress toward the yearly EPS goal of $1.26-$1.36.
Confirms:Q2 EPS reported at or above $0.24.
Disproves:Q2 EPS reported below $0.24.
Why it matters: If revenue growth speeds up, it could signal a stronger health care sector. This may benefit Pennant Group.
Confirms:Health care sector revenue growth is speeding up toward 10% or more.
Disproves:Revenue growth keeps slowing down and is below 10%.
Why it matters: Updates on EPS guidance will clarify progress toward the annual target of $1.26-$1.36.
Confirms one read:Management raises EPS guidance to the higher end of the $1.26-$1.36 range.
Confirms the other:Management cuts EPS guidance to less than $1.26.
Why it matters: Adjusted EPS is important for meeting the annual target of $1.26-$1.36. A miss could raise concerns.
Confirms:Adjusted EPS for Q2 is reported below $0.32.
Disproves:Adjusted EPS for Q2 meets or exceeds $0.32.
Why it matters: EBITDA is crucial for achieving the annual target of $94.2M-$100.0M. A lower figure could signal issues.
Confirms:Q2 EBITDA is reported below $21.7M.
Disproves:Q2 EBITDA meets or exceeds $21.7M.
Why it matters: Home health admissions growth is vital for future revenue. A slowdown could indicate market challenges.
Confirms:Home health admissions growth is reported below 62.7% year over year.
Disproves:Home health admissions growth meets or exceeds 62.7% year over year.
